Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease

医学 神经炎症 神经退行性变 疾病 帕金森病 临床试验 神经科学 生物信息学 药理学 内科学 生物
作者
Chien‐Tai Hong,Jia‐Hung Chen,Chaur‐Jong Hu
出处
期刊:Journal of Biomedical Science [BioMed Central]
卷期号:31 (1): 102-102 被引量:38
标识
DOI:10.1186/s12929-024-01090-x
摘要

Abstract Neurodegenerative diseases, including Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system. The potential of numerous antidiabetic agents to modify neurodegenerative disease progression, both preclinically and clinically, has been assessed. These agents may provide additional therapeutic benefits beyond glycemic control. Introduced in the twenty-first century, glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of antidiabetic drugs noted not only for their potent glucose-lowering effects but also for their cardiovascular and renal protective benefits. Various GLP-1RAs have been demonstrated to have significant benefits in in vitro and in vivo models of neurodegenerative diseases through modulating a variety of pathogenic mechanisms, including neuroinflammation, autophagy, mitochondrial dysfunction, and the abnormal phosphorylation of pathognomonic proteins. These agents also have substantial protective effects on cognitive and behavioral functions, such as motor function. However, clinical trials investigating GLP-1RAs in diseases such as AD, PD, mild cognitive impairment, psychiatric disorders, and diabetes have yielded mixed results for cognitive and motor function. This review examines the link between diabetes and neurodegenerative diseases, explores the effects of antidiabetic agents on neurodegeneration, provides a concise overview of the GLP-1 pathway, and discusses both preclinical and clinical trial outcomes of GLP-1RAs for neurodegenerative diseases, including their effects on cognition in AD and PD. This review also proposed new strategies for the design of future clinical trials on GLP-1 RAs for both AD and PD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
zhumeili完成签到,获得积分10
1秒前
未白发布了新的文献求助10
1秒前
misscloud发布了新的文献求助10
1秒前
人间慈悲的应助被西西采纳,获得10
1秒前
cz完成签到 ,获得积分10
2秒前
2秒前
123131发布了新的文献求助10
2秒前
4秒前
lindollar发布了新的文献求助10
4秒前
搞怪的老九的应助被小吴采纳,获得20
4秒前
zhumeili发布了新的文献求助10
4秒前
5秒前
September完成签到 ,获得积分10
5秒前
独特振家完成签到,获得积分10
5秒前
Edward完成签到,获得积分10
6秒前
Xie完成签到,获得积分20
6秒前
xldongcn发布了新的文献求助10
7秒前
wangqing完成签到,获得积分10
7秒前
9秒前
9秒前
9秒前
搞怪巨人发布了新的文献求助10
9秒前
10秒前
10秒前
科研通AI2S的应助被孤独的沛春采纳,获得10
11秒前
wananaikedai发布了新的文献求助10
11秒前
打打的应助被KEKEKE采纳,获得10
11秒前
12秒前
12秒前
菜鸟学习发布了新的文献求助10
12秒前
充电宝的应助被忧虑的从阳采纳,获得10
13秒前
13秒前
香蕉觅云的应助被会飞的生菜采纳,获得20
13秒前
风中冬灵完成签到,获得积分10
14秒前
Xk发布了新的文献求助10
14秒前
Li完成签到,获得积分10
14秒前
14秒前
67发布了新的文献求助10
14秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187226
求助须知:如何正确求助?哪些是违规求助? 9575395
关于积分的说明 21841040
捐赠科研通 7784958
什么是DOI,文献DOI怎么找? 3434935
关于科研通互助平台的介绍 2559355
邀请新用户注册赠送积分活动 2481808